292 related articles for article (PubMed ID: 25623738)
21. De Ritis (aspartate transaminase/alanine transaminase) ratio as a significant predictor of recurrence-free survival in patients with upper urinary tract urothelial carcinoma following nephroureterectomy.
Nishikawa M; Miyake H; Fujisawa M
Urol Oncol; 2016 Sep; 34(9):417.e9-417.e15. PubMed ID: 27180325
[TBL] [Abstract][Full Text] [Related]
22. Low preoperative lymphocyte-monocyte ratio (LMR) represents a potentially poor prognostic factor in nonmetastatic clear cell renal cell carcinoma.
Hutterer GC; Stoeckigt C; Stojakovic T; Jesche J; Eberhard K; Pummer K; Zigeuner R; Pichler M
Urol Oncol; 2014 Oct; 32(7):1041-8. PubMed ID: 25027686
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of preoperative lymphocyte to monocyte ratio in patients with nonmetastatic clear cell renal cell carcinoma.
Chang Y; Fu Q; Xu L; Zhou L; Liu Z; Yang Y; Lin Z; Xu J
Tumour Biol; 2016 Apr; 37(4):4613-20. PubMed ID: 26508025
[TBL] [Abstract][Full Text] [Related]
24. Association of preoperative serum De Ritis ratio with oncological outcomes in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinoma.
Laukhtina E; Pradere B; D Andrea D; Rosiello G; Luzzago S; Pecoraro A; Palumbo C; Knipper S; Karakiewicz PI; Margulis V; Quhal F; Sari Motlagh R; Mostafaei H; Mori K; Kimura S; Enikeev D; Shariat SF
Urol Oncol; 2020 Dec; 38(12):936.e7-936.e14. PubMed ID: 32962909
[TBL] [Abstract][Full Text] [Related]
25. Association between De Ritis ratio (aspartate aminotransferase/alanine aminotransferase) and oncological outcomes in bladder cancer patients after radical cystectomy.
Ha YS; Kim SW; Chun SY; Chung JW; Choi SH; Lee JN; Kim BS; Kim HT; Yoo ES; Kwon TG; Kim WT; Kim WJ; Kim TH
BMC Urol; 2019 Jan; 19(1):10. PubMed ID: 30678673
[TBL] [Abstract][Full Text] [Related]
26. The AST/ALT Ratio Is an Independent Prognostic Marker for Disease-free Survival in Stage II and III Colorectal Carcinoma.
Scheipner L; Smolle MA; Barth D; Posch F; Stotz M; Pichler M; StÖger H; Gerger A; Riedl JM
Anticancer Res; 2021 Jan; 41(1):429-436. PubMed ID: 33419840
[TBL] [Abstract][Full Text] [Related]
27. Prognostic impact of preoperative neutrophil-to-lymphocyte ratio in localized nonclear cell renal cell carcinoma.
de Martino M; Pantuck AJ; Hofbauer S; Waldert M; Shariat SF; Belldegrun AS; Klatte T
J Urol; 2013 Dec; 190(6):1999-2004. PubMed ID: 23831313
[TBL] [Abstract][Full Text] [Related]
28. Increased preoperative levels of plasma fibrinogen and D dimer in patients with renal cell carcinoma is associated with poor survival and adverse tumor characteristics.
Erdem S; Amasyali AS; Aytac O; Onem K; Issever H; Sanli O
Urol Oncol; 2014 Oct; 32(7):1031-40. PubMed ID: 25027687
[TBL] [Abstract][Full Text] [Related]
29. Transaminase Activity Predicts Survival in Patients with Head and Neck Cancer.
Takenaka Y; Takemoto N; Yasui T; Yamamoto Y; Uno A; Miyabe H; Ashida N; Shimizu K; Nakahara S; Hanamoto A; Fukusumi T; Michiba T; Cho H; Yamamoto M; Inohara H
PLoS One; 2016; 11(10):e0164057. PubMed ID: 27732629
[TBL] [Abstract][Full Text] [Related]
30. Predictive value of De Ritis ratio in metastatic renal cell carcinoma treated with tyrosine-kinase inhibitors.
Janisch F; Klotzbücher T; Marks P; Kienapfel C; Meyer CP; Yu H; Fühner C; Hillemacher T; Mori K; Mostafei H; Shariat SF; Fisch M; Dahlem R; Rink M
World J Urol; 2021 Aug; 39(8):2977-2985. PubMed ID: 33649869
[TBL] [Abstract][Full Text] [Related]
31. Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers.
Minervini A; Di Cristofano C; Gacci M; Serni S; Menicagli M; Lanciotti M; Salinitri G; Rocca CD; Lapini A; Nesi G; Bevilacqua G; Minervini R; Carini M
J Urol; 2008 Oct; 180(4):1284-9. PubMed ID: 18707725
[TBL] [Abstract][Full Text] [Related]
32. Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European study.
Cindolo L; Patard JJ; Chiodini P; Schips L; Ficarra V; Tostain J; de La Taille A; Altieri V; Lobel B; Zigeuner RE; Artibani W; Guillé F; Abbou CC; Salzano L; Gallo C
Cancer; 2005 Oct; 104(7):1362-71. PubMed ID: 16116599
[TBL] [Abstract][Full Text] [Related]
33. A retrospective pilot study to examine the potential of aspartate aminotransferase to alanine aminotransferase ratio as a predictor of postoperative acute kidney injury in patients with hepatocellular carcinoma.
Xu J; Xia Y; Li S; Cheng X; Hu S; Gao Y; Zhou X; Wang G; Zheng Q
Ann Clin Biochem; 2019 May; 56(3):357-366. PubMed ID: 30453754
[TBL] [Abstract][Full Text] [Related]
34. The AST/ALT (De Ritis) Ratio Predicts Survival in Patients with Oral and Oropharyngeal Cancer.
Knittelfelder O; Delago D; Jakse G; Reinisch S; Partl R; Stranzl-Lawatsch H; Renner W; Langsenlehner T
Diagnostics (Basel); 2020 Nov; 10(11):. PubMed ID: 33228184
[TBL] [Abstract][Full Text] [Related]
35. Elevated Preoperative Serum Alanine Aminotransferase/Aspartate Aminotransferase (ALT/AST) Ratio Is Associated with Better Prognosis in Patients Undergoing Curative Treatment for Gastric Adenocarcinoma.
Chen SL; Li JP; Li LF; Zeng T; He X
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27294917
[TBL] [Abstract][Full Text] [Related]
36. The De Ritis ratio as prognostic biomarker of in-hospital mortality in COVID-19 patients.
Zinellu A; Arru F; De Vito A; Sassu A; Valdes G; Scano V; Zinellu E; Perra R; Madeddu G; Carru C; Pirina P; Mangoni AA; Babudieri S; Fois AG
Eur J Clin Invest; 2021 Jan; 51(1):e13427. PubMed ID: 33043447
[TBL] [Abstract][Full Text] [Related]
37. Pretreatment Lymphocyte to Monocyte Ratio is an Independent Prognostic Factor in Metastatic Clear Cell Renal Cell Carcinoma.
Gu L; Ma X; Xie Y; Li H; Wang L; Chen L; Zhao W; Zhang Y; Zhang X
Clin Genitourin Cancer; 2017 Jun; 15(3):e369-e377. PubMed ID: 28038932
[TBL] [Abstract][Full Text] [Related]
38. Tumor associated trypsin inhibitor as a prognostic factor in renal cell carcinoma.
Paju A; Jacobsen J; Rasmuson T; Stenman UH; Ljungberg B
J Urol; 2001 Mar; 165(3):959-62. PubMed ID: 11176522
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of pretreatment serum alanine aminotransferase/aspartate aminotransferase (ALT/AST) ratio and gamma glutamyltransferase (GGT) in patients with esophageal squamous cell carcinoma.
Huang H; Wang XP; Li XH; Chen H; Zheng X; Lin JH; Kang T; Zhang L; Chen PS
BMC Cancer; 2017 Aug; 17(1):544. PubMed ID: 28806937
[TBL] [Abstract][Full Text] [Related]
40. Validation of the pre-treatment neutrophil-lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients.
Pichler M; Hutterer GC; Stoeckigt C; Chromecki TF; Stojakovic T; Golbeck S; Eberhard K; Gerger A; Mannweiler S; Pummer K; Zigeuner R
Br J Cancer; 2013 Mar; 108(4):901-7. PubMed ID: 23385728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
